Antivenom or antivenin is a medication made from antibodies that are used to treat certain venomous bites and stings. Antivenom is recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved, and it is given by injection. It includes serum sickness, shortness of breath, and allergic reactions. Antivenom is made by collecting venom from the related animal and injecting small amounts of it into a domestic animal.
MARKET DYNAMICS
The anti-venom market in robust R&D activities is resulting from an increasing number of pipeline products, which may drive the growth of the global anti-venom market. However, the rise in awareness about the presence of anti-venoms has lowered ignorance toward venom-bites, which is restraining the market growth. Moreover, the launch of new products with improved shelf life and extended expiry date is expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Anti-Venom Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in anti-venom market with detailed market segmentation by type, reptile, mode of action and geography. The anti-venom market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in anti-venom market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The anti-venom market is segmented on the basis of type, reptile and mode of action. Based on type the market is segmented as monovalent antivenom and polyvalent antivenom. On the basis of reptile the market is categorized as snake, scorpion, spider and others (if any). On the basis of mode of action the market is categorized as cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic and others (if any).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in anti-venom market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-venom market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting anti-venom market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-venom market in these regions.
MARKET PLAYERS
The report covers key developments in the in anti-venom market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in anti-venom market are anticipated to have lucrative growth opportunities in the future with the rising demand for in anti-venom market in the global market. Below mentioned is the list of few companies engaged in the anti-venom market.
The report also includes the profiles of key in anti-venom market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Alomone Labs, Ltd.
- Boehringer Ingelheim International GmbH.
- BTG International Ltd.
- CSL Limited
- Flynn Pharma (Micropharm)
- Haffkine Bio-Pharmaceutical Corporation Limited
- Laboratorios Silanes
- Merck & Co.
- Pfizer Inc.
- Sigma-Aldrich Co.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.